Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AP Pharma's APF530 Poised To Return To FDA Review
Seeking Alpha
Tuesday, December 20, 2011 - 7:50pm
tags:
APF530, AP Pharma, FDA, chemotherapy-induced nausea and vomiting, CINV
FDA accepts application for Pfizer arthritis drug
Yahoo/AP
Tuesday, December 20, 2011 - 7:49pm
tags:
Pfizer, FDA, rheumatoid arthritis, tofacitinib
Generics makers step up for shortages response
Fierce Drug Manufacturing
Tuesday, December 20, 2011 - 12:12pm
tags:
generics, drug shortages
Progenics, Salix Surge After Constipation Drug Shows Benefits in Trial
Bloomberg
Tuesday, December 20, 2011 - 12:09pm
tags:
Salix, Progenics Pharmaceuticals, methylnaltrexone, opiod-induced constipation
Bayer predicts blockbuster success for four of its late-stage drugs
Fierce Biotech
Tuesday, December 20, 2011 - 11:24am
tags:
Bayer, Xarelto, VEGF Trap-Eye, regorafenib, Alpharadin
Teva Drops Most in a Month in Tel Aviv on U.S. Lipitor Sales
Bloomberg
Tuesday, December 20, 2011 - 11:22am
tags:
Teva Pharmaceuticals, Lipitor, generics
Prestige buys rights to GSK OTC meds for $660M
Fierce Pharma
Tuesday, December 20, 2011 - 11:15am
tags:
OTC, GSK, M&A, Prestige Brands
Novartis ends study of drug in high risk patients
Reuters
Tuesday, December 20, 2011 - 11:14am
tags:
Novartis, Tekturna, hypertension
10 Biotech Stock Predictions for 2012
TheStreet.com
Tuesday, December 20, 2011 - 11:13am
tags:
Amgen, FDA, Oncothyreon, Merck KGaA, Vical, GSK, Seattle Genetics, M&A, Celgene, Biomarin, Amag Pharmaceuticals, Momenta, ONYX Pharmaceuticals, Cell Therapeutics, Roche, Aeterna Zentaris, Arena Pharmaceuticals, Vertex, Spectrum Pharmaceuticals
Eli Lilly and Immunogen enter development deal for potential cancer treatments
Yahoo/AP
Tuesday, December 20, 2011 - 11:05am
tags:
Eli Lilly, Immunogen, Targeted Antibody Payload, cancer
Oncothyreon Files Investigational New Drug Application for ONT-10
Yahoo
Tuesday, December 20, 2011 - 11:04am
tags:
Oncothyreon, ONT-10, cancer, vaccines
What Can We Expect From CytRx In 2012?
Seeking Alpha
Tuesday, December 20, 2011 - 10:54am
tags:
CytRx, Bafetinib, INNO-206
Alexza And Somaxon: 2 Distressed Biotechs On Sale And Up For Sale
Seeking Alpha
Tuesday, December 20, 2011 - 10:51am
tags:
Somaxon, Alexza
AstraZeneca abandoning anti-ovarian cancer drug, warns antidepressant not testing well
Yahoo/AP
Tuesday, December 20, 2011 - 10:50am
tags:
antidepressants, Targacept, ovarian cancer, AstraZeneca, TC-5214, olaparib
Astra Zeneca Slides Towards the Patent Cliff
WSJ Online
Tuesday, December 20, 2011 - 10:33am
tags:
patents, AstraZeneca, Seroquel XR, Crestor
Lilly Has A 20% Downside; Pfizer Safer
Seeking Alpha
Tuesday, December 20, 2011 - 10:27am
tags:
Lilly, Pfizer, solanezumab
Targacept: What's Left After Latest TC-5214 Disappointment?
Seeking Alpha
Tuesday, December 20, 2011 - 10:25am
tags:
TC-5214, Targacept, AstraZeneca, depression
Sanofi Says MS Pill Aubagio Fails to Beat Rebif in Trial
Bloomberg
Tuesday, December 20, 2011 - 10:23am
tags:
Sanofi, MS, Aubagio, Rebif, multiple sclerosis, Merck KGaA
Teva Pursues First Type 1 Diabetes Treatment Since Insulin
Bloomberg
Monday, December 19, 2011 - 10:15pm
tags:
Teva Pharmaceuticals, type 1 diabetes, DiaPep277, Sanofi
Pharma Fraud Continues To Fill The US Treasury
Pharmalot
Monday, December 19, 2011 - 4:24pm
tags:
fraud, Merck Serono, Novo Nordisk, False Claims Act

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.